IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐Cov‐2) with digital drug development

• Главные авторы: Agata Blasiak (Автор), Jhin Jieh Lim (Автор), Shirley Gek Kheng Seah (Автор), Theodore Kee (Автор), Alexandria Remus (Автор), De Hoe Chye (Автор), Pui San Wong (Автор), Lissa Hooi (Автор), Anh T. L. Truong (Автор), Nguyen Le (Автор), Conrad E. Z. Chan (Автор), Rishi Desai (Автор), Xianting Ding (Автор), Brendon J. Hanson (Автор), Edward Kai‐Hua Chow (Автор), Dean Ho (Автор)
• Формат: ‌
• Опубликовано: Wiley, 2021-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Abstract The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) led to multiple drug repurposing clinical trials that have yielded largely uncertain outcomes. To overcome this challenge, we used IDentif.AI, a platform that pairs experimental validation with artificial intellig...